Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: Misclassification rates defined as upgrading, upstaging, and upgrading and/or upstaging have not been tested in contemporary Black patients relative to White patients who fulfilled criteria for very-low-risk, low-risk, or favorable intermediate-risk prostate cancer. This study aimed to address this void. Methods: Within the SEER database (2010-2015), we focused on patients with very low, low, and favorable intermediate risk for prostate cancer who underwent radical prostatectomy and had available stage and grade information. Descriptive analyses, temporal trend analyses, and multivariate logistic regression analyses were used. Results: Overall, 4,704 patients with very low risk (701 Black vs 4,003 White), 17,785 with low risk (2,696 Black vs 15,089 White), and 11,040 with favorable intermediate risk (1,693 Black vs 9,347 White) were identified. Rates of upgrading and/or upstaging in Black versus White patients were respectively 42.1% versus 37.7% (absolute Δ =14.4%; P

Cite

CITATION STYLE

APA

Stolzenbach, L. F. anziska, Rosiello, G., Pecoraro, A., Palumbo, C., Luzzago, S., Deuker, M., … Karakiewicz, P. I. (2020). Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients. JNCCN Journal of the National Comprehensive Cancer Network, 18(11), 1492–1499. https://doi.org/10.6004/JNCCN.2020.7580

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free